Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus

被引:19
作者
Smith, CL
Brown, I
Torraca, BM
机构
[1] Ferris State Univ, Coll Pharm, Dept Pharm Practice, Big Rapids, MI USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Allergy Immunol & Infect Dis, New Brunswick, NJ USA
[3] Parke Davis, Med & Sci Affairs, Morris Plains, NJ USA
关键词
D O I
10.1086/516993
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1477 / 1478
页数:2
相关论文
共 10 条
[1]   ACETYLATION PHENOTYPE AND CUTANEOUS HYPERSENSITIVITY TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HIV-INFECTED PATIENTS [J].
CARR, A ;
GROSS, AS ;
HOSKINS, JM ;
PENNY, R ;
COOPER, DA .
AIDS, 1994, 8 (03) :333-337
[2]  
CRIBB AE, 1990, MOL PHARMACOL, V38, P744
[3]   ADVERSE EVENTS ASSOCIATED WITH TRIMETHOPRIM-SULFAMETHOXAZOLE AND ATOVAQUONE DURING THE TREATMENT OF AIDS-RELATED PNEUMOCYSTIS-CARINII PNEUMONIA [J].
HUGHES, WT ;
LAFON, SW ;
SCOTT, JD ;
MASUR, H .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1295-1301
[4]   N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus [J].
Kaufmann, GR ;
Wenk, M ;
Taeschner, W ;
Peterli, B ;
Gyr, K ;
Meyer, UA ;
Haefeli, WE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (01) :62-67
[5]  
LEEDER JS, 1991, BIOCHEM PHARMACOL, V41, P567
[6]   Intracellular glutathione in the peripheral blood cells of HIV-infected patients: Failure to show a deficiency [J].
Pirmohamed, M ;
Williams, D ;
Tingle, MD ;
Barry, M ;
Khoo, SH ;
OMahony, C ;
Wilkins, EGL ;
Breckenridge, AM ;
Park, BK .
AIDS, 1996, 10 (05) :501-507
[7]  
RIEDER MJ, 1988, J PHARMACOL EXP THER, V244, P724
[8]   CAFFEINE AS A METABOLIC PROBE - VALIDATION OF ITS USE FOR ACETYLATOR PHENOTYPING [J].
TANG, BK ;
KADAR, D ;
QIAN, L ;
IRIAH, J ;
YIP, J ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (06) :648-657
[9]   ADVERSE REACTIONS TO COTRIMOXAZOLE IN HIV-INFECTION [J].
VANDERVEN, AJAM ;
KOOPMANS, PP ;
VREE, TB ;
VANDERMEER, JWM .
LANCET, 1991, 338 (8764) :431-433
[10]  
WEBER WW, 1985, PHARMACOL REV, V37, P25